Clinical Pharmacology of Miami, Inc.

Miami, Florida FL 33014-3616

0 studies enrolling now · 39 studies all time

What they study most

Attention Deficit Hyperactivity Disorder (ADHD), Binge-Eating Disorder Disorder, Bioequivalence - Irritation and Sensitization Potential of Transdermal Patch, Chronic Hepatitis B Virus Infection, Chronic Hepatitis C Virus Infection, Cytomegalovirus (CMV), Diabetes, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Type 2, Dyslipidemias, Endometriosis, Female Sexual Health

Studies at this site

• GT-032 Belapectin Hepatic Impairment — Completed
• A Study to Evaluate the Pharmacokinetics of Divarasib in Healthy Participants and Participants With Impaired Hepatic Function — Completed
• Assessment of the Single Dose Pharmacokinetics and Tolerability of Sativex in Patients With Impaired Hepatic Function and Healthy Patients — Completed
• Evaluate Pharmacokinetics and Safety of BMS-986177 in Participants With Normal Renal Function and With Moderate or Severe Renal Impairment — Completed
• Pharmacokinetic Interaction Between SSP-004184 (SPD602) and Midazolam in Healthy Adult Subjects — Completed
• Effect of SSP-004184 (SPD602) on the Pharmacokinetics of Simvastatin in Healthy Adult Subjects — Completed
• Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC — Completed
• Taste Assessment Study of SHP429 in Healthy Adult Subjects — Completed
• Bioavailability Study of SPD489 Administered With Two Different Means of Administration in Healthy Adult Volunteers — Completed
• Study of SHP620 (Maribavir) in Healthy Adults — Completed
• A Study to Evaluate LY3202328 in Overweight Healthy Participants and Dyslipidemia — Completed
• A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics and Safety and Tolerability of a Single Oral Dose of Risdiplam Compared to Matched Healthy Participants With Normal Hepatic Function — Completed
• Pharmacokinetics and Safety of Vilaprisan in Renal Impairment — Completed
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of KQ-791 in Diabetes Mellitus — Completed
• A Study of Ipatasertib in Participants With Mild, Moderate or Severe Hepatic Impairment Compared to Healthy Participants — Completed
• Pharmacokinetics of Bictegravir in Adults With Normal and Impaired Renal Function — Completed
• Single-dose Escalation Study of SQ-001 Infusion to Characterize the PK Profiles of Major Sentinel Compounds in Healthy Adult Volunteers in US — Completed
• A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GLWL-01 — Stopped early
• Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of DS-1150b in Healthy Subjects and Subjects With Type-2 Diabetes Mellitus — Completed
• Pharmacokinetic Study Of AGILE AG200-15 After Weekly Application Under Various Conditions in Healthy Female Volunteers — Completed
• Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM — Completed
• MAD Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PB-119 to Subjects With T2DM — Completed
• A Study to Investigate the Effect of Renal Function and Hemodialysis on the Pharmacokinetics (PK) of RO7079901 — Completed
• Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction — Completed
• Irritation and Sensitization Potential of Repeat Applications of Rotigotine Patch — Completed
• A Open-Label, Within-Subject Dose-Escalation Study to Evaluate the Clinical Safety and Pharmacokinetic Profile of a Topical Sildenafil Cream (5% w/w), in Healthy Postmenopausal Women — Completed
• Safety and Tolerability Study of Oral LGD-6972 for Type 2 Diabetes Mellitus — Completed
• Evaluate the Safety and PK of Proellex® in Female Patients With Impaired Hepatic Function and Healthy Adults — Completed
• Evaluate PK and Safety of Proellex® in Females With Various Stages of Impaired Renal Function and Healthy Females — Stopped early
• To Assess the Effect of Renal Impairment on the Blood Levels of Daclatasvir (DCV), Asunaprevir (ASV) and BMS-791325 After Multiple Doses of a Fixed Dose Combination Tablet — Completed
• Safety and Pharmacokinetic (PK) Study of Oral Bendavia Administered for 7 Days — Completed
• Pharmacokinetics of Tasimelteon in Subjects With Renal Impairment and Matched Control Subjects With Relatively Normal Renal Function — Completed
• A Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP4058 Following Single Oral Doses — Completed
• Hepatic Impairment Trial of Obeticholic Acid — Completed
• Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction — Completed
• Mechanisms of Glucose Lowering Effect of Colesevelam HCl — Completed
• Multiple Ascending Dose Study of BMS-820132 in Patients With Type 2 Diabetes — Completed
• Single Ascending Dose Study of BMS-820132 in Patients With Type 2 Diabetes — Completed
• Study to Evaluate Safety, Tolerability, and Pharmacokinetics (PK) of Intravenous (IV) Infusion of MTP-131 (Bendavia™) in Healthy Adults — Completed